bms 961 has been researched along with Dermatitis, Atopic in 1 studies
BMS 961: a retinoic acid receptor gamma agonist; no further info available 10/2006
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M | 1 |
| Hener, P | 1 |
| Zhang, Z | 1 |
| Kato, S | 1 |
| Metzger, D | 1 |
| Chambon, P | 1 |
1 other study available for bms 961 and Dermatitis, Atopic
| Article | Year |
|---|---|
Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis.
Topics: Administration, Topical; Animals; Calcitriol; Calcium; Cells, Cultured; Cytokines; Dermatitis, Atopi | 2006 |